Is NGL Fine-Chem the Best Stock in Its Sector? A Look at the Numbers

Is NGL Fine-Chem the best stock in its sector? The stock trades on the NSE at Rs 2,930 as of 05 October 2026, within its 52-week range of Rs 1,271.00 to Rs 3,602.00. NGL Fine-Chem Ltd manufactures veterinary and human active pharmaceutical ingredients, intermediates and finished formulations, with veterinary APIs the bulk of its business.

NGL Fine-Chem sits in the Healthcare sector, and its 14.62% ROE and 31.61x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector's Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

About NGL Fine-Chem

NGL Fine-Chem Ltd manufactures veterinary and human active pharmaceutical ingredients, intermediates and finished formulations, with veterinary APIs the bulk of its business. The stock is trading about 19 percent below its 52-week high after more than doubling from its 52-week low. At a market capitalisation of Rs 1,808 Cr, it is tracked as part of the Healthcare sector on Univest.

Is NGL Fine-Chem the Best Stock in Its Sector?

NGL Fine-Chem makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 14.62% ROE with a 31.61x P/E against the sector's 37.53x Industry P/E. NGL Fine-Chem's 31.61x P/E is below the 37.53x Industry P/E with a 14.62% ROE, though a 5.49x price to book and a concentrated animal health product base are worth weighing after the stock more than doubled from its 52-week low.

Metric	NGL Fine-Chem
CMP (NSE)	Rs 2,930.00
52-Week High / Low	Rs 3,602.00 / Rs 1,271.00
Market Cap	Rs 1,808 Cr
P/E (TTM) vs Industry P/E	31.61x vs 37.53x
P/B	5.49
ROE	14.62%
EPS (TTM)	Rs 92.56
Dividend Yield	0.06%
Debt to Equity	0.33

Compare NGL Fine-Chem Against Other Healthcare Sector Stocks

How NGL Fine-Chem Compares Against Its Healthcare Sector Peers

The table below sets NGL Fine-Chem against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company	Market Cap (Rs Cr)	P/E	ROE	Debt to Equity
NGL Fine-Chem	1,808	31.61	14.62%	0.33
Lincoln Pharmaceuticals	1,172	12.15	11.60%	0.01
Kilitch Drugs India	771	26.41	10.79%	0.32
Peer average (2 companies)	-	19.28	11.20%	0.17

Against this peer set, NGL Fine-Chem's 14.62% ROE is above the 11.20% peer average, and its P/E of 31.61x runs above the peer average of 19.28x. NGL Fine-Chem's 31.61x P/E is below the 37.53x Industry P/E with a 14.62% ROE, though a 5.49x price to book and a concentrated animal health product base are worth weighing after the stock more than doubled from its 52-week low.

What Makes NGL Fine-Chem Worth Watching in Healthcare

• Below Industry P/E: A 31.61x P/E against a 37.53x Industry P/E is a discount for a business with a 14.62% ROE.
• Solid ROE, moderate leverage: A 14.62% ROE alongside a debt to equity ratio of 0.33 reflects a reasonably efficient, manageable balance sheet.
• Animal health concentration: Veterinary APIs make up the large majority of sales, which gives NGL Fine-Chem a specialised niche but also a concentrated product base.

NGL Fine-Chem Valuation: Is It Justified?

NGL Fine-Chem's 31.61x P/E is below the 37.53x Industry P/E with a 14.62% ROE, though a 5.49x price to book and a concentrated animal health product base are worth weighing after the stock more than doubled from its 52-week low. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Nelcast the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track NGL Fine-Chem and other Healthcare sector stocks.

How to Track NGL Fine-Chem Before You Invest

Before deciding whether NGL Fine-Chem deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

1. Open the Univest Screener and search for NGL Fine-Chem to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
2. Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

NGL Fine-Chem earns a place in the best stock in its sector conversation on the strength of a 14.62% ROE and a P/E of 31.61x against a 37.53x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Is NGL Fine-Chem the best stock in its sector?

Ans. NGL Fine-Chem has a 14.62% ROE and trades at 31.61x P/E against a 37.53x Industry P/E, and compares above the peer average ROE of 11.20% in this article's named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of NGL Fine-Chem?

Ans. NGL Fine-Chem was trading at Rs 2,930.00 on the NSE as of 05 October 2026, within its 52-week range of Rs 1,271.00 to Rs 3,602.00.

What sector does NGL Fine-Chem belong to?

Ans. NGL Fine-Chem is classified under the Healthcare sector on Univest.

How does NGL Fine-Chem compare to its sector peers on P/E?

Ans. NGL Fine-Chem's P/E of 31.61x is above the 19.28x average of the 2 named peers compared in this article.

What is NGL Fine-Chem's return on equity?

Ans. NGL Fine-Chem reported a return on equity of 14.62%, which is above the 11.20% average of its named peers in this comparison.

Should I invest in NGL Fine-Chem based on its sector position?

Ans. NGL Fine-Chem's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.

{"@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [{"@type": "Question", "name": "Is NGL Fine-Chem the best stock in its sector?", "acceptedAnswer": {"@type": "Answer", "text": "NGL Fine-Chem has a 14.62% ROE and trades at 31.61x P/E against a 37.53x Industry P/E, and compares above the peer average ROE of 11.20% in this article's named comparison, so the answer depends on what an investor is prioritising."}}, {"@type": "Question", "name": "What is the current share price of NGL Fine-Chem?", "acceptedAnswer": {"@type": "Answer", "text": "NGL Fine-Chem was trading at Rs 2,930.00 on the NSE as of 05 October 2026, within its 52-week range of Rs 1,271.00 to Rs 3,602.00."}}, {"@type": "Question", "name": "What sector does NGL Fine-Chem belong to?", "acceptedAnswer": {"@type": "Answer", "text": "NGL Fine-Chem is classified under the Healthcare sector on Univest."}}, {"@type": "Question", "name": "How does NGL Fine-Chem compare to its sector peers on P/E?", "acceptedAnswer": {"@type": "Answer", "text": "NGL Fine-Chem's P/E of 31.61x is above the 19.28x average of the 2 named peers compared in this article."}}, {"@type": "Question", "name": "What is NGL Fine-Chem's return on equity?", "acceptedAnswer": {"@type": "Answer", "text": "NGL Fine-Chem reported a return on equity of 14.62%, which is above the 11.20% average of its named peers in this comparison."}}, {"@type": "Question", "name": "Should I invest in NGL Fine-Chem based on its sector position?", "acceptedAnswer": {"@type": "Answer", "text": "NGL Fine-Chem's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor."}}]}